Danbin Wu
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Inflammasome and immune disorders 4
- Gut microbiota and health 2
-
- Rheumatoid Arthritis Research and Therapies 3
- Systemic Lupus Erythematosus Research 2
- Co-authors
- Yingxin Sun (6 shared papers)Xijuan Jiang (7 shared papers)Qing Gao (6 shared papers)Huhu Li (3 shared papers)Bin Yu (3 shared papers)Wenyun Zeng (3 shared papers)Lin Yang (2 shared papers)Yefei Chen (2 shared papers)
- Journals
- Frontiers in Pharmacology (2 papers)Cellular Reprogramming (1 paper)Scientific Reports (1 paper)Cell Death and Disease (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- China
In The Last Decade
Danbin Wu
14 papers receiving 521 citations
Peers
Comparison fields: 5 of 87
- Biological Psychiatry 24
- Nephrology 49
- Molecular Biology 394
- Immunology 121
- Cancer Research 81
Countries citing papers authored by Danbin Wu
This map shows the geographic impact of Danbin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danbin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danbin Wu more than expected).
Fields of papers citing papers by Danbin Wu
This network shows the impact of papers produced by Danbin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danbin Wu. The network helps show where Danbin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Danbin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 130 | |
| 2 | 2019 | 124 | |
| 3 | 2018 | 121 | |
| 4 | 2021 | 56 | |
| 5 | 2022 | 18 | |
| 6 | 2020 | 15 | |
| 7 | 2024 | 14 | |
| 8 | 2020 | 14 | |
| 9 | 2023 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 2 | |
| 13 | 2017 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2023 | 0 | |
| 16 | 2025 | 0 |
About Danbin Wu
Danbin Wu is a scholar working on Molecular Biology, Rheumatology, Surgery, Oncology and Hematology, having authored 16 papers that have together received 526 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Gut microbiota and health (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Systemic Lupus Erythematosus Research (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Biological Psychiatry (24 citations), Nephrology (49 citations), Molecular Biology (394 citations), Immunology (121 citations) and Cancer Research (81 citations). Danbin Wu has collaborated with scholars based in China. Frequent co-authors include Yingxin Sun, Xijuan Jiang, Qing Gao, Huhu Li, Bin Yu, Wenyun Zeng, Lin Yang, Yefei Chen, Hao Deng and Chun Sun. Their work appears in journals such as Frontiers in Pharmacology, Cellular Reprogramming, Scientific Reports, Cell Death and Disease and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.